APX – Citi rates the stock as Buy
Buy rating and $17.10 target price are retained.
Read MoreBroker News
TRP – Morgans rates the stock as Speculative Buy
Morgans initiates coverage on Tissue Repair with a Speculative Buy rating and $1.43 target price.
Read MoreCHN – Macquarie rates the stock as Outperform
Target rises to $10.70 from $9.80, Outperform retained.
Read MoreWOW – Credit Suisse rates the stock as Underperform
The broker retains its Underperform rating and $31.84 target price.
Read MorePMV – Credit Suisse rates the stock as Neutral
The Neutral rating is unchanged and the target falls to $28.71 from $28.74.
Read MoreOTW – Morgans rates the stock as Hold
Morgans retains its Hold rating and $5.75 target price.
Read MoreQAN – Credit Suisse rates the stock as Underperform
The target price of $4.10 and Underperform rating are unchanged, despite the analyst increasing the estimated loss for FY22 to -$1.6bn from -$1.2bn.
Read MoreDHG – UBS rates the stock as Buy
UBS upgrades Domain Holdings to Buy from Neutral. Target price is steady at $5.80.
Read MoreGUD – Credit Suisse rates the stock as Outperform
The target price of $4.10 is unchanged, despite the analyst increasing the estimated loss for FY22 to -$1.6bn from -$1.2bn. The broker is cautious on taking a more positive stance and retains its Underperform rating.
Read MoreAFG – Morgans rates the stock as Add
Target price rises to $3.60 from $3.40. Add rated.
Read MoreRIO – UBS rates the stock as Sell
UBS retains a Sell rating, noting the iron ore outlook remains fragile as port inventories build. $79 target price retained.
Read MoreILU – Credit Suisse rates the stock as Neutral
Credit Suisse retains its Neutral rating and $9 target price.
Read MoreSVW – UBS rates the stock as Buy
The target rises to $27.15 from $26.25 after marking-to-market listed investments and making minor EPS upgrades.
Read MoreANZ – Credit Suisse rates the stock as Neutral
The Neutral rating and target price of $28.50 for ANZ Bank are retained.
Read MoreRIO – Morgans rates the stock as Hold
The broker’s Hold rating is maintained. Target price falls to $104 from $112.
Read MoreAMP – Citi rates the stock as Neutral
Neutral (High Risk) and $1.25 target retained for now.
Read MorePPM – Credit Suisse rates the stock as Outperform
Credit Suisse maintains Outperform after dropping its target to $3.05 from $3.35.
Read MoreKGN – UBS rates the stock as Neutral
Neutral rating and $10 target price retained.
Read MoreDXS – Macquarie rates the stock as Outperform
Outperform retained, target rises to $11.93 from $11.90.
Read MoreHVN – UBS rates the stock as Buy
The Buy rating and $7 target price are retained.
Read MoreMPL – Credit Suisse rates the stock as Outperform
The Outperform rating and $3.70 target price are retained.
Read MoreHVN – Credit Suisse rates the stock as Neutral
Neutral rating and target eases to $5.61 from $5.65.
Read MoreBHP – Morgans rates the stock as Add
Target falls to $45.70 from $46.05, Add retained.
Read MoreVSL – UBS rates the stock as Buy
UBS initiates coverage on Vulcan steel with a Buy rating and $9 target.
Read MoreTNE – Credit Suisse rates the stock as Neutral
Credit Suisse increases its target price for Technology One to $12 from $9.50, Neutral rating maintained.
Read MoreBSL – Citi rates the stock as Buy
Buy retained. But Citi has lowered its target PE multiple to 17x from 20x, which leads to a target price decrease to $25.50 from $27.50.
Read MoreMGH – Morgans rates the stock as Add
Despite the potential for an upside earnings surprise, the broker retains its $5.65 target price. The Add rating is unchanged.
Read MoreSLR – Macquarie rates the stock as Outperform
The target price of $2.10 is unchanged. Outperform rated.
Read MoreIAG – Macquarie rates the stock as Outperform
The broker acknowledges short-term risk yet believes the stock is cheap. The Outperform rating and $5.40 target are unchanged.
Read MoreWPR – Morgans rates the stock as Add
Waypoint remains suited to income investors with distributions paid quarterly, suggests Morgans. Add and $3.00 target retained.
Read MoreMVF – Macquarie rates the stock as Outperform
The target price lifts to $1.15 from $1.10. The Outperform rating is maintained.
Read MoreAX1 – Citi rates the stock as Neutral
Neutral retained, the target rises to $2.99 from $2.14 due to to earnings revisions, higher multiples and a roll forward of valuation measures.
Read MoreCBA – Citi rates the stock as Sell
Citi retains its Sell rating and $94.50 target price.
Read MoreEHL – Macquarie rates the stock as Outperform
Outperform retained, target falls to $1.27 from $1.35.
Read MoreTWE – Morgans rates the stock as Add
Recent share price weakness is seen as a buying opportunity and Morgans retains its Add rating and lifts its target price to $14.06 from $13.90.
Read MoreALQ – Credit Suisse rates the stock as Outperform
The Outperform rating is retained and the target price increases to $14.70 from $14.10.
Read MoreAPE – Morgans rates the stock as Add
The broker reduces its target price to $17.20 from $20.45. The Add rating rating is maintained, given the potential for EA123 strategy execution and ongoing efficiency improvements.
Read MoreALX – Macquarie rates the stock as Outperform
Macquarie upgrades Atlas Arteria to Outperform from Hold. Target price rises 35c to $6.87 to reflect improved cash flow and a 30 basis point cut in bond forecasts.
Read MoreCBA – Morgans rates the stock as Reduce
The broker maintains its Reduce rating and still feels the stock trades at an unjustified premium relative to peers.The target price falls to $73 from $80.
Read MoreOZL – Macquarie rates the stock as Outperform
Target price is steady at $32. Outperform rating retained.
Read More
